Last reviewed · How we verify

NCT06919146: AGPAP

After-school Game-Based Physical Activity Program Improves Physical Fitness of 9-10-Year-Old Children

Completed NA Last updated 9 April 2025
What this trial tests

NA trial testing Physical Activity in Physical Activity in 130 participants. Completed in 7 December 2020.

Timeline
1 July 2020
Primary endpoint
27 August 2020
7 December 2020

Quick facts

Lead sponsorElvin Onarici Gungor
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment130
Start date1 July 2020
Primary completion27 August 2020
Estimated completion7 December 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Elvin Onarici Gungor

Who can join

Adults 9 to 10, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the effect of an afterschool game-based physical activity program (AGPAP) on children's PF. This study was randomized controlled trial involving 120 children from a state school in Eskisehir/Turkey. The CONSORT checklist was used in this study. The sample of 9-10 years children (n = 120) was divided into groups by randomization. The intervention consisted of AGPAP. For PF, handgrip strength, curl-ups, sit-and-reach, standing long jump, and 10-meter running speed tests were applied.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A 12-week afterschool game-based physical activity program improves physical fitness of 9-10-year-old children: a randomized controlled study.
    Onarici Gungor E, Yaliz Solmaz D, Guven G, Gurol B. · · 2025 · PMID 41345233 · DOI 10.1038/s41598-025-31429-9

Verify or expand the search:

Other trials of Physical Activity

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06919146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing